Everyone's obsessed with the obvious AI stocks - NVIDIA, Palantir, Vertiv - but honestly there's a whole tier of companies quietly benefiting from this spending spree that most retail traders aren't even on the radar for.

I've been keeping close tabs on Photronics lately. It's one of those unsexy but absolutely critical plays in the chip-making supply chain that doesn't get enough attention. They make photomasks - basically the stencils that print circuits onto semiconductor wafers - and as AI chips get more complex, their role becomes even more essential. The stock had a solid breakout late February but couldn't hold it, which is frustrating from a technical perspective. That said, the fundamentals are still firing on all cylinders.

Their latest earnings showed record revenue on the high end, especially strong in the US market. What's interesting is that as these AI chips become more sophisticated, Photronics' revenue potential scales right along with it. They're also throwing serious capital into expansion - CapEx jumped from $131 million in fiscal 2024 to $188.1 million in their latest year. That's the kind of investment you want to see from a company betting big on future growth in the chip industry.

Then there's Teradyne, which is up about 40% year-to-date and honestly deserving of more discussion. They manufacture the testing equipment that chip makers use to validate their products. The fastest-growing segment? You guessed it - AI data center chips and accelerators. More complex chips mean more rigorous testing requirements, and AI chips right now are about as complex as they come. The stock's momentum has been impressive compared to the broader market.

Both of these companies have solid earnings revision trends and analyst support, which suggests institutional money is starting to notice them too. Sure, they've pulled back recently like everything else, but the structural tailwinds from the AI boom aren't going anywhere. If you're looking beyond the mega-cap ai stocks for some exposure to the infrastructure beneficiaries, these are worth having on your watchlist.